Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 60 resultados

RADAR-CNS: Remote Assessment of Disease and Relapse in Central Nervous System Disorders GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un H2020: H2020-JTI-IMI2-2015-03-two-stage Background: Long term conditions require monitoring of patients, traditionally conducted in the clinic, to monitor treatment effects, advers...
2016-03-31 - 2022-03-31 | Financiado

SVDs-at-target: Small vessel diseases in a mechanistic perspective Targets for Intervention Affected pathways and m... GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un H2020: H2020-PHC-2014-2015 Stroke and dementia rank among the most pressing health issues in Europe. Cerebral small vessel diseases (SVDs) have emerged as a central li...
2015-12-15 - 2021-12-31 | Financiado

RELENT: RELapses prevENTion in chronic autoimmune disease common mechanisms and co morbidities GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un H2020: H2020-PHC-2014-2015 RELENT is multidisciplinary group of scientists and clinical investigators whose goal is to develop individualized treatment for chronic aut...
2015-12-09 - 2020-04-30 | Financiado

SENSE-Cog: Ears Eyes and Mind The SENSE Cog Project to improve mental well being for elderly Europeans with... GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un H2020: H2020-PHC-2014-2015 Mental, cognitive, vision and hearing health problems in elderly people are amongst the top 10 public health challenges in Europe. They freq...
2015-12-09 - 2022-06-30 | Financiado

HemAcure: Application of combined gene and cell therapy within an implantable therapeutic device for the treat... GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un H2020: H2020-PHC-2014-2015 The main objective of the HemAcure project is to develop and refine the tools and technologies for a novel ex vivo prepared cell based thera...
2015-12-09 - 2018-10-31 | Financiado

FOLSMART: Folate Target Nanodevices To Activated Macrophages For Rheumatoid Arthritis GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un H2020: H2020-NMP-2014-2015 FOLSMART will bring to phase I clinical trials novel folate-based nanodevices (FBN) for the treatment of rheumatoid arthritis (RA). These na...
2015-11-25 - 2020-12-31 | Financiado

DIACAT: Diamond materials for the photocatalytic conversion of CO2 to fine chemicals and fuels using visible... GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un H2020: H2020-FETOPEN-2014-2015 In DIACAT we propose the development of a completely new technology for the direct photocatalytic conversion of CO2 into fine chemicals and...
2015-05-26 - 2019-12-31 | Financiado

PRECIOUS: PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un H2020: H2020-PHC-2014-2015 Every year, 1.3 million Europeans have a stroke and one million ultimately die of stroke. One third of stroke patients remain dependent on t...
2015-04-07 - 2022-11-30 | Financiado

TREGeneration: Repair of tissue and organ damage in refractory chronic graft versus host disease after hematopoieti... GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un H2020: H2020-PHC-2014-2015 Our proposal encompasses parallel clinical trials addressing the feasibility and the effectiveness of donor-derived regulatory T cells (Treg...
2014-12-01 - 2021-12-31 | Financiado

CANCER-ID: Cancer treatment and monitoring through identification of circulating tumour cells and tumour relate... GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP6: Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential...
2015-01-01 - 2019-12-31 | Financiado

EUC²LID: European Lead Factory GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP6: The European Lead Factory concept proposed by the EUC2LID Consortium relates to the discovery of novel small molecule candidates to serve as...
2013-01-01 - 2018-05-31 | Financiado

EU-AIMS: European Autism Interventions - A Multicentre Study for Developing New Medications GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP6: Despite dramatic advances in molecular and imaging technologies, there are currently no effective pharmacological treatments for the core sy...
2012-04-01 - 2018-03-31 | Financiado

ONCOTRACK: OncoTrack - Methods for systematic next generation oncology biomarker development GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP6: We propose here an exhaustive analysis of the genome, exome, methylome and transcriptome of primary tumours and metastases from patients wit...
2011-01-01 - 2016-12-31 | Financiado

NEWMEDS: Novel Methods leading to New Medications in Depression and Schizophrenia GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP6: Despite dramatic advances in molecular and imaging technologies and nearly 1 5,000 articles on schizophrenia and depression (S&D) there are...
2009-09-01 - 2015-02-28 | Financiado

NEWMEDS: Novel Methods leading to New Medications in Depression and Schizophrenia GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP7: Despite dramatic advances in molecular and imaging technologies and nearly 1 5,000 articles on schizophrenia and depression (S&D) there are...
Financiado

CARDIORISK: The mechanisms of cardiovascular risks after low radiation doses GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP7: Recent epidemiologic evidence suggests that moderate and low radiation doses to the heart may result in a moderate, but significant increase...
Financiado

EU-CERT-ICD: Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverte... GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP7: An estimated 500.000 sudden cardiac deaths (SCD) occur each year in the European Union. Patients at risk for SCD may benefit from prophylact...
Financiado

OSPI-EUROPE: Optimizing suicide prevention programs and their implementation in Europe GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP7: Suicide is a serious public health problem in the EU calling for effective interventions. The aim of this project is to provide EU member st...
Financiado

ESGI: European Sequencing and Genotyping Infrastructure GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP7: The objective of this project is the integration of world class high-throughput sequencing and genotyping facilities that will provide seque...
Financiado

EPIMIRNA: MicroRNAs in the Pathogenesis Treatment and Prevention of Epilepsy GABOMI GESELLSCHAFT FUR ABLAUFORGANISATIONMILLIARIUM MBH CO KG participó en un FP7: Epilepsy is a major burden for patients and health systems worldwide. It is a common chronic neurological disorder affecting people of all a...
Financiado

GABO:mi